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Objectives: Clostridium difficile is a causative agent of
nosocomial diarrhoea worldwide including KSA. Anti-
biotic treatment of C. difficile infections has been asso-
ciated with infection recurrence after cessation of
treatment. This study sought to use natural preparations
of Nigella sativa seeds (black seed) and Commiphora
myrrha (Myrrh) to inhibit the growth of C. difficile.
Methods: Black seedoil andwater extract andMyrrhwater
extract were examined for their antibacterial activity against
two strains of C. difficile and four other gram-positive and
gram-negative bacteria using the agar diffusion technique.
The antibacterial effects of these herbal preparations were
also characterized under neutral and acidic pH values.
Results: Black seed oil (2%) and Myrrh water extract
were found to inhibit the growth of C. difficile strains.
Black seed oil (2%) could also inhibit other pathogens
including Bacillus cereus and Vibrio cholera. The anti-
bacterial activity of black seed oil (2%) and Myrrh water
extract was not affected by varying the pH from 4.5 to
7.0. These herbal preparations also maintained their ac-
tivity against pathogens at a very lower pH of 1.5 (the
average stomach pH).
Conclusions: This study presents black seed oil (2%) and
Myrrh water extract as effective natural antibacterial
agents for inhibiting C. difficile growth for the treatment
of human infections and in food preservation applications.
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K.M. Aljarallah428IntroductionClostridium difficile is a Gram-positive spore-forming
anaerobic bacterium that has been associated with
antibiotic-related diarrhoea and life-threatening pseudo-
membranous enterocolitis.1 It is reported to be the leading
causative agent of nosocomial diarrhoea in the Americas,
Europe and Asia.2 The pathogenicity of C. difficile relies
upon its ability to express two main types of toxins,
namely, toxin A and toxin B.3 Both toxins show cytotoxic
activities resulting from the inactivation of Rho-GTPases,
leading to disruption of the cytoskeleton in invaded host
cells and subsequent cell death.4,5 The two toxins were also
reported to be enterotoxic causing intestinal epithelial
damage, increased mucosal permeability and acute
inflammation.6 Infection is facilitated by various risk
factors including ageing, underlying diseases, extended
treatment with antibiotics, administration of multiple
antibiotics, use of anti-ulcer medications, long-term resi-
dence in care facilities, hospitalization, immunosuppression,
cancer, gastrointestinal disorders, and gastrointestinal sur-
gery.3,7 However, this does not exclude the possibility of
infection in young adults and other individuals who are not
exposed to these risk factors.3
The incidence rate and severity of C. difficile infection
(CDI) have risen over the last decade.8 In the USA, the
incidence of CDI in hospitalized patients has increased
dramatically from 31 cases per 100,000 patients in 1996 to
84 cases per 100,000 patients in 2005, with estimates of
400,000 cases reported per year.9,10 This has resulted in an
economic burden of $3 billion on the healthcare system. A
February, 2015 report by the Center for Disease Control
(CDC) showed that 29,000 patients died within 30 days of
the initial CDI diagnosis.11 In the early 2000s, outbreaks of
severe and recurrent CDI were reported in hospitals
throughout North America, and these outbreaks were
caused by almost the same hypervirulent C. difficile BI/
NAP1/027 strain.2 In Germany, the rate is 5e20 cases per
100,000 persons every year.12
The prevalence of CDI in the Middle East has also been
studied. It was reported that 13.7% of 300 hospitalized adult
patients in Jordon were infected with C. difficile.13 In KSA, a
two-year observational study was conducted on the inci-
dence of C. difficile-associated diarrhoea (CDAD) in a KSA
hospital. This study showed that 4.6% of 913 patients’
specimens were positive for C. difficile toxins and that there
was an increase in the incidence rate of CDI during 2007e
2008.14 In another study, an antibiotic-resistant hyperviru-
lent strain of C. difficile was detected in a tertiary care centre
in Riyadh, KSA.15 Together, these reports highlight the
significance of CDI as a health threat in this country.
Administration of antibiotics including metronidazole,
vancomycin, or fidaxomicin is typically used for controlling
CDI. However, the use of these antibiotics has been found to
be associated with CDI recurrence in some patients following
cessation of antibiotic treatment.2 This was particularly
evident with hypervirulent C. difficile strains such as BI/
NAP1/r027. The intestinal microbiota transplantation
(IMT) treatment has been used to combat CDI recurrence
by infusing intestinal microorganisms in a suspension of
donor stool into the intestine of the infected patient.16 IMTserves to re-establish the balance of normal microbiota in
the intestine by providing beneficial bacteria to antagonize
C. difficile. In very severe CDI cases, surgery was necessary.12
Given the above concerns about antibiotics, and the
inconvenience of IMT and medical surgery, alternative
therapeutic strategies are needed to overcome CDI.
Herbal extracts and essential oils are potential therapeutic
candidates for treating CDI.17 Different herbs have already
been used to treat various bacterial infections.18,19
Compared to antibiotics, herbal extracts and essential oils
contain several antibacterial compounds that could employ
different inhibitory mechanisms, making it difficult for
pathogens to develop resistance.20 Seeds of Nigella sativa
L. have been used as a natural product for treating various
diseases in the Middle East for over 2000 years.19 Their
efficacy has been attributed to the presence of many active
compounds in the seeds including thymoquinone (TQ),
which possesses antibacterial and antifungal activities.21
For instance, a diethyl ether extract of N. sativa seeds was
found to inhibit different gram-positive and gram-negative
bacteria including Staphylococcus aureus, Pseudomonas aer-
uginosa and Escherichia coli. This extract showed antibac-
terial synergism with streptomycin and gentamicin.22 Other
studies have also reported antibacterial activity for N.
sativa seeds against Bacillus subtilis, E. coli, Klebsiella
pneumoniae, Salmonella Typhimurium and Shigella
flexneri.23e25 N. sativa, was also found to be useful in the
eradication of Helicobacter pylori in patients with non-
ulcer dyspepsia.26 TQ was shown to have antibacterial
activity against 11 human pathogenic bacteria especially
the gram-positive cocci S. aureus (ATCC 25923) and
Staphylococcus epidermidis (CIP 106510).21
Myrrh (Commiphora myrrha) is another plant that has
also been used in different medical contexts as an astringent,
antiseptic, antiparasitic, and antitussive and for treating
leprosy, syphilis and cancer.27 Different extracts of Myrrh
have reportedly shown antibacterial activity against E. coli,
S. aureus, Bacillus subtilis, Bacillus circulans, Enterococcus
faecalis, P. aeruginosa, and H. pylori.28e30 To the best of
my knowledge, there have been no reports addressing the
potential use of N. sativa seeds or Myrrh to eradicate the
C. difficile infection.
Thus, the present study was designed to examine the
antibacterial activity of N. sativa seeds and Myrrh against
C. difficile compared with other bacteria including E. coli,
Bacillus cereus, Lactobacillus spp. and Vibrio cholerae.Materials and Methods
Culture and growth conditions
Five different bacterial species were examined in this
study including 3 Gram-positive bacteria of C. difficile
strains JIR and VPI, Bacillus cereus and Lactobacillus and 2
gram-negative species of E. coli MG1655, and V. cholerae.
These bacteria were supplied by the Department of Micro-
biology at the University of Pennsylvania Perelman School
of Medicine. All cultures were stored frozen at 80 C.
C. difficile strains were sub-cultured by spreading a heavy
inoculum from the frozen culture onto brain heart
Table 1: Antibacterial effect of Nigella sativa seed oil, water
extract of Nigella sativa seeds and Commiphora myrrha
against C. difficile and other gram-positive and -negative
bacteria.





C. difficile JIR e e þþ e þþ
C. difficile VPI e e þþ e þþ
B. cereus e e þþ þþ þ
Lactobacillus sp e e þ e e
E. coli e e þ e e
V. cholerae e e þþ e e
(): No antibacterial effect
(þ): Antibacterial effect with inhibition zone of <15 mm.
(þþ): Antibacterial effect with inhibition zone of 15 mm.
Inhibition of Clostridium difficile by natural herbal extracts 429infusion-supplemented (BHIS) agar plates containing 37 g/
Lt brain heart infusion, 5 g/Lt yeast extract, 0.1% (w/v) L-
cysteine, 0.1% (w/v) taurocholate and 8 mg/mL cefoxitin.
Prior to inoculation, dried BHIS plates were left under
anaerobic conditions for a minimum of 2 h. Inoculated plates
were incubated anaerobically at 37 C for 20 h. Other bac-
terial cultures were prepared by inoculation from their frozen
stocks onto LuriaeBertani (LB) agar plates followed by in-
cubation at 37 C for 20 h.
Preparation of herbal oils and cold water extracts
Black seed (N. sativa) oil (cold press extracted, volatile and
fixed oil preserved by Al-Hussan Food Products Factory e
Riyadh, KSA) was purchased from local markets in Riyadh,
KSA. Different oil concentrations of 0.5%, 1.0% and 2.0%
were prepared by dilution in methanol, followed by cold
storage in sterilized bottles until use.31 Cold water extracts of
black seed were prepared by grinding the seeds using a coffee
grinder, followed by mixing with cold water (1:10 seeds:
water). The dried Myrrh (C. myrrha) chunks were broken
inside their bags into small pieces before grinding. Next,
ground Myrrh was mixed with cold water (1:10 Myrrh:
water). Each solution was put into a conical flask containing
a magnetic flea and stirred in a cold room (5 C) for three
days. The black seed solution was then centrifuged twice at
3100 rpm for 15 min, and supernatants were further
centrifuged at 13,000 rpm for 5 min. The resulting
supernatants were kept refrigerated until use. Myrrh
solution was purified using a 100 mm nylon mesh filter and
stored under refrigeration.
Assessment of the antibacterial effect of herbal oils and
water extracts
The agar diffusion method was used to assess the anti-
bacterial activity of herbal oils and water extracts. C. difficile
strains grown on BHIS plates for 20 h were inoculated into
BHIS broth followed by incubation at 37 C for 5 h under
anaerobic conditions. The other bacterial cultures including
E. coli, Bacillus cereus, Lactobacillus spp. and V. cholerae
were prepared by inoculating their 20 h cultures on LB agar
into LB broth followed by incubation at 37 C for 5 h. An
aliquot of each bacterial suspension was streaked onto the
LB agar, followed by the application of sterile filter paper
discs impregnated with different concentrations (0.5%, 1.0%
and 2.0%) of black seed oil in methanol, methanol alone
(control treatment), black seed water extract and Myrrh
water extract. Plates were then incubated at 37 C for 24 h
under either anaerobic conditions (C. difficile strains) or
aerobic conditions (the other examined cultures). The effect
of herbal extracts was examined by observing the formation
of a clear zone around the disks.
Results
Antibacterial effect of black seed and Myrrh
The antibacterial effect of black seed oil and water extract
and Myrrh water extract on two strains of C. difficile
compared with other gram-positive (Gþ) and gram-negative(G) bacteria was examined using the agar diffusion
method. It can be seen in Table 1 that the use of black seed oil
at concentrations of 0.5% and 1.0% was not associated with
any inhibitory effect on C. difficile strains. Whereas, the two
strains of the pathogen were inhibited by the application of a
higher (2.0%) concentration of black seed oil. Black seed oil
also had an antibacterial effect on the other gram-positive
and gram-negative microorganisms, but only at a concen-
tration of 2.0% (Table 1). However, the inhibitory effect of
black seed oil (2.0%) on C. difficile, B. cereus, and
V. cholerae was higher compared to Lactobacillus sp. and
E. coli, suggesting that this effect was independent of the
organism being Gram-positive or Gram-negative. Water
extract of black seeds did not, however, show any antibac-
terial effect against C. difficile and the other examined bac-
teria with the exception of B. cereus (Table 1). In contrast,
Myrrh water extract was highly effective against C. difficile
strains, could also inhibit B. cereus but did not affect the
other tested organisms including Lactobacillus sp., E. coli
and V. cholerae.
Effect of pH on the antibacterial activity of black seed oil
and Myrrh water extract
To ensure that the antibacterial effect of black seed oil
(2%) and Myrrh water extract was due to their chemical
components rather than acidic pH, both preparations were
neutralized to pH 7.0 and examined for their antibacterial
activity against C. difficile strains using the agar diffusion
assay. Table 2 shows that there was no difference between the
antibacterial effect of black seed oil (2%) and Myrrh water
extract at a pH of 4.5 and 7.0. This indicated that the
inhibitory effect of these natural preparations relied upon
their chemical composition, rather than acidic pH.
Effect of stomach pH on the antibacterial activity of black
seed oil and Myrrh water extract
The ability of black seed oil and Myrrh water extract to
inhibit C. difficile, as suggested by the above results, could
also be extended to treating human infection with this
pathogen. An effective oral treatment with these natural
antibacterial preparations would however require the
Table 2: Effect of pH on the antibacterial activity of black seed
(Nigella sativa) oil (2%) and Myrrh (Commiphora myrrha)
water extract against C. difficile.
Microorganism Black seed oil (2%) Myrrh water extract
pH 4.5 pH 7.0 pH 4.5 pH 7.0
C. difficile JIR þþ þþ þþ þþ
C. difficile VPI þþ þþ þþ þþ
(þþ): Antibacterial effect with inhibition zone of 15 mm.
K.M. Aljarallah430stability of their inhibitory components against the highly
acidic environment of the stomach. Therefore, the antibac-
terial activity of black seed oil (2%) and Myrrh water extract
acidified to a pH of 1.5 (average stomach pH) was examined.
Both natural preparations maintained their antibacterial ef-
fect for up to 3 h at this very acidic pH (data not shown). This
finding demonstrates that the acidic environment of the
stomach does not compromise the effectiveness of treating
human infection with C. difficile by oral administration of
black seed oil (2%) and Myrrh water extract.
Discussion
The present study addressed the use of natural herbal
preparations of N. sativa seeds (black seed) and C. myrrha
(Myrrh) to inactivate C. difficile, which is the leading caus-
ative agent of nosocomial diarrhoea worldwide. The inci-
dence of C. difficile extends to the Americas, Europe and
Asia, including KSA.2,14,15 The negative health side effects of
antibiotics and the recurrence of C. difficile infection after
cessation of treatment highlight the need for alternative
therapies. Natural herbal preparations could be a potential
candidate for inhibiting C. difficile given previous studies
reporting their effectiveness against other infectious
bacteria.17e25
The present results show that the use of black seed oil
(2%) and Myrrh water extract can inhibit the growth of the
C. difficile strains examined in this study. Black seed oil (2%)
also effectively inhibited the growth of other important
pathogens including B. cereus and V. cholerae. Myrrh water
extract could also inhibit C. difficile and B. cereus. In addi-
tion to their pathogenicity, C. difficile and B. cereus can resist
heat treatments frequently applied in food preservation by
forming protective spores. Severe heat treatments are
required to eradicate these spore-forming pathogens, which
negatively affects food quality. The application of black seed
oil and Myrrh water extract could serve as an effective,
alternative cold treatment to inhibit C. difficile and B. cereus
without adverse effects on food sensory attributes. The re-
sults also showed that the antibacterial activity of these
herbal preparations was due to their chemical composition
rather than acidic pH because neutralizing them to a pH of
7.0 did not affect their inhibitory effect on C. difficile.
Further lowering of the pH to that of the very acidic envi-
ronment of the stomach (pH 1.5) also did not reduce the
ability of the herbal preparation to inhibit the pathogen.
Taken together, these results suggest that black seed oil (2%)
andMyrrh water extract are effective antibacterial agents for
inhibiting C. difficile in foods and during human infection.The findings of this study are consistent with previous
reports showing antibacterial activity for black seed and
Myrrh against diverse microorganisms including E. coli, S.
aureus, P. aeruginosa, K. pneumoniae, Salmonella Typhimu-
rium, S. flexneri, Bacillus circulans, E. faecalis and H. py-
lori.24,28e30 However, the present study adds pertinent
knowledge by showing that black seed oil and Myrrh could
also inhibit C. difficile, which is a significant causative
agent of nosocomial diarrhoea worldwide. Compared to
antibiotics, herbal extracts are advantageous in that they
contain several inhibitory compounds, which makes it
unlikely that pathogens will develop resistance against their
antibacterial effects.20 This suggests that these natural
products are potential candidates for replacing synthetic
antibiotics in the future.
Recommendations
Considering the promising results observed in this work,
further investigation is recommended to determine and
extract the effective compounds responsible for the inhibi-
tory effect, as well as to explore the effects of both herbs on
C. difficile pathogenesis including toxin gene expression and
colonization in animal models, through the use of molecular
biology and genomic approaches.
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